Edition:
United States

Anatara Lifesciences Ltd (ANR.AX)

ANR.AX on Australia Stock Exchange

1.55AUD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$1.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,317
52-wk High
$1.61
52-wk Low
$0.72

Chart for

About

Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of... (more)

Overall

Beta: --
Market Cap(Mil.): $74.86
Shares Outstanding(Mil.): 49.41
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 197.02 15.79
EPS (TTM): -- -- --
ROI: -- -10.12 12.01
ROE: -- -37.71 15.91

BRIEF-Anatara and Zoetis to negotiate terms of an international Detach commercial agreement

* Anatara and Zoetis to negotiate terms of an international Detach® commercial agreement Source text for Eikon: Further company coverage:

Aug 21 2017

BRIEF-Anatara Lifesciences seeks trading halt

* Seeks trading halt pending announcement regarding evaluation and license option agreement Source text for Eikon: Further company coverage:

Aug 16 2017

Earnings vs. Estimates